Caribou Biosciences Stock Analysis

Caribou Stock Analysis Notes

About 53.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.88. Some equities with similar Price to Book (P/B) outperform the market in the long run. Caribou Biosciences has Price/Earnings To Growth (PEG) ratio of 0.5. The entity recorded a loss per share of 1.62. The firm had not issued any dividends in recent years. Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. The company was incorporated in 2011 and is headquartered in Berkeley, California. Caribou Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. For more info on Caribou Biosciences please contact Rachel Haurwitz at 510 982 6030 or go to https://cariboubio.com.

Caribou Biosciences Investment Alerts

Caribou Biosciences Upcoming and Recent Events

Caribou Largest EPS Surprises

View All Earnings Estimates

Caribou Biosciences Environmental, Social, and Governance (ESG) Scores

Caribou Stock Institutional Investors

Note, although Caribou Biosciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Caribou Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 192.52 M.

Caribou Profitablity

Management Efficiency

Caribou Biosciences has return on total asset (ROA) of (0.2921) % which means that it has lost $0.2921 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5276) %, meaning that it created substantial loss on money invested by shareholders. Caribou Biosciences' management efficiency ratios could be used to measure how well Caribou Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.5 in 2025. Return On Capital Employed is likely to drop to -0.62 in 2025. Non Current Liabilities Total is likely to gain to about 30.7 M in 2025, whereas Total Current Liabilities is likely to drop slightly above 24.8 M in 2025.

Technical Drivers

As of the 22nd of July, Caribou Biosciences shows the Mean Deviation of 5.37, downside deviation of 6.3, and Risk Adjusted Performance of 0.248. Caribou Biosciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Caribou Biosciences Price Movement Analysis

Caribou Biosciences Insider Trading Activities

Caribou Biosciences Outstanding Bonds

Caribou Biosciences Predictive Daily Indicators

Caribou Biosciences Forecast Models

Caribou Biosciences' time-series forecasting models are one of many Caribou Biosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Caribou Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Caribou Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Caribou shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Caribou Biosciences. By using and applying Caribou Stock analysis, traders can create a robust methodology for identifying Caribou entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Caribou analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Caribou analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Caribou Biosciences stock analysis indicators help investors evaluate how Caribou Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Caribou Biosciences shares will generate the highest return on investment. By understating and applying Caribou Biosciences stock analysis, traders can identify Caribou Biosciences position entry and exit signals to maximize returns.

When running Caribou Biosciences' price analysis, check to measure Caribou Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Caribou Biosciences is operating at the current time. Most of Caribou Biosciences' value examination focuses on studying past and present price action to predict the probability of Caribou Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Caribou Biosciences' price. Additionally, you may evaluate how the addition of Caribou Biosciences to your portfolios can decrease your overall portfolio volatility.